美股异动 | 脑再生科技盘前大涨64% 昨日一度暴涨4.3倍 年内累涨64208%
脑再生科技(RGC.US)盘前一度大涨64.65%至98.79美元。该股昨日盘中一度暴涨434%至83.6美元,股价创历史新高,年内飙升642倍(涨幅64207.69%)。最终收涨283.13%报60美元,市值逼近300亿美元。脑再生科技是一家早期生物科学公司,当下备受瞩目的脑机接口技术引爆股价。今年5月9日,脑再生科技宣布其新一代神经调控芯片通过FDA临床试验审批,将与全球顶尖医疗机构梅奥诊所合作,开展帕金森病治疗研究。今年6月2日,该公司宣布进行38比1的股票拆分,股票分配定于6月13日,拆分后的交易定于6月16日(即昨日,本周一)进行。流通股规模扩大后,散户投资者蜂拥入场,但流通股数量极少,推升股价飙涨。值得注意的是,截至2024年6月末,脑再生科技尚未从销售任何产品中获得任何收入,2021至2024财年,公司营收为0,且其核心疗法需通过FDA三期临床,失败概率高达80%(行业均值)。脑再生科技在2024财年财报中表示:“可能永远无法盈利”“持续经营存在不确定性”。(格隆汇)


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.